ID EZH1_MOUSE Reviewed; 747 AA. AC P70351; A2A4K5; Q3TPR1; Q3U3V5; Q3UU02; Q8BR85; Q922L1; Q9R089; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1997, sequence version 1. DT 04-NOV-2026, entry version 187. DE RecName: Full=Histone-lysine N-methyltransferase EZH1; DE EC=2.1.1.356 {ECO:0000269|PubMed:19026780}; DE AltName: Full=ENX-2; DE AltName: Full=Enhancer of zeste homolog 1; GN Name=Ezh1; Synonyms=Enx2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=9214638; DOI=10.1093/emboj/16.11.3219; RA Laible G., Wolf A., Dorn R., Reuter G., Nislow C., Lebersorger A., RA Popkin D., Pillus L., Jenuwein T.; RT "Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate RT gene silencing in Drosophila heterochromatin and at S. cerevisiae RT telomeres."; RL EMBO J. 16:3219-3232(1997). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RX PubMed=9473645; DOI=10.1016/s0167-4781(97)00156-5; RA Ogawa M., Hiraoka Y., Taniguchi K., Aiso S.; RT "Cloning and expression of a human/mouse Polycomb group gene, ENX- RT 2/Enx-2."; RL Biochim. Biophys. Acta 1395:151-158(1998). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=129/Sv; RX PubMed=10051331; DOI=10.1007/s003359900993; RA Laible G., Haynes A.R., Lebersorger A., O'Carroll D., Mattei M.-G., RA Denny P., Brown S.D.M., Jenuwein T.; RT "The murine polycomb-group genes ezh1 and ezh2 map close to hox gene RT clusters on mouse chromosomes 11 and 6."; RL Mamm. Genome 10:311-314(1999). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=ILS, and ISS; RX PubMed=11471062; DOI=10.1007/s00335-001-1001-x; RA Ehringer M.A., Thompson J., Conroy O., Xu Y., Yang F., Canniff J., RA Beeson M., Gordon L., Bennett B., Johnson T.E., Sikela J.M.; RT "High-throughput sequence identification of gene coding variants within RT alcohol-related QTLs."; RL Mamm. Genome 12:657-663(2001). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC STRAIN=C57BL/6J, and NOD; RC TISSUE=Aorta, Cerebellum, Corpora quadrigemina, Hippocampus, and Vein; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [8] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=FVB/N; TISSUE=Mammary tumor; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [9] RP FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS RP SPECTROMETRY, AND IDENTIFICATION IN THE PRC2/EED-EZH1 COMPLEX. RX PubMed=19026780; DOI=10.1016/j.molcel.2008.10.016; RA Shen X., Liu Y., Hsu Y.-J., Fujiwara Y., Kim J., Mao X., Yuan G.-C., RA Orkin S.H.; RT "EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in RT maintaining stem cell identity and executing pluripotency."; RL Mol. Cell 32:491-502(2008). RN [10] RP IDENTIFICATION IN THE PRC2 COMPLEX. RX PubMed=20144788; DOI=10.1016/j.stem.2009.12.014; RA Walker E., Chang W.Y., Hunkapiller J., Cagney G., Garcha K., Torchia J., RA Krogan N.J., Reiter J.F., Stanford W.L.; RT "Polycomb-like 2 associates with PRC2 and regulates transcriptional RT networks during mouse embryonic stem cell self-renewal and RT differentiation."; RL Cell Stem Cell 6:153-166(2010). RN [11] RP INTERACTION WITH EZHIP. RX PubMed=31451685; DOI=10.1038/s41467-019-11800-x; RA Ragazzini R., Perez-Palacios R., Baymaz I.H., Diop S., Ancelin K., RA Zielinski D., Michaud A., Givelet M., Borsos M., Aflaki S., Legoix P., RA Jansen P.W.T.C., Servant N., Torres-Padilla M.E., Bourc'his D., Fouchet P., RA Vermeulen M., Margueron R.; RT "EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells."; RL Nat. Commun. 10:3858-3858(2019). CC -!- FUNCTION: Polycomb group (PcG) protein. Catalytic subunit of the CC PRC2/EED-EZH1 complex, which methylates 'Lys-27' of histone H3, leading CC to transcriptional repression of the affected target gene. Able to CC mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, CC H3K27me2 and H3K27me3, respectively. Required for embryonic stem cell CC derivation and self-renewal, suggesting that it is involved in CC safeguarding embryonic stem cell identity. Compared to EZH2-containing CC complexes, it is less abundant in embryonic stem cells, has weak CC methyltransferase activity and plays a less critical role in forming CC H3K27me3, which is required for embryonic stem cell identity and proper CC differentiation. {ECO:0000269|PubMed:19026780}. CC -!- CATALYTIC ACTIVITY: CC Reaction=L-lysyl(27)-[histone H3] + 3 S-adenosyl-L-methionine = CC N(6),N(6),N(6)-trimethyl-L-lysyl(27)-[histone H3] + 3 S-adenosyl-L- CC homocysteine + 3 H(+); Xref=Rhea:RHEA:60292, Rhea:RHEA-COMP:15535, CC Rhea:RHEA-COMP:15548, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, CC ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:61961; CC EC=2.1.1.356; Evidence={ECO:0000269|PubMed:19026780}; CC -!- SUBUNIT: Component of the PRC2/EED-EZH1 complex, which includes EED, CC EZH1, SUZ12, RBBP4 and AEBP2. The PRC2/EED-EZH1 is less abundant than CC the PRC2/EED-EZH2 complex, has weak methyltransferase activity and CC compacts chromatin in the absence of the methyltransferase cofactor S- CC adenosyl-L-methionine (SAM). Interacts with EZHIP; the interaction CC blocks EZH1 methyltransferase activity (PubMed:31451685). CC {ECO:0000269|PubMed:19026780, ECO:0000269|PubMed:20144788, CC ECO:0000269|PubMed:31451685}. CC -!- INTERACTION: CC P70351; Q62315: Jarid2; NbExp=4; IntAct=EBI-2531737, EBI-493592; CC P70351; Q02395: Mtf2; NbExp=3; IntAct=EBI-2531737, EBI-2531578; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Colocalizes with CC trimethylated 'Lys-27' of histone H3. {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P70351-1; Sequence=Displayed; CC Name=2; CC IsoId=P70351-2; Sequence=VSP_036388; CC -!- TISSUE SPECIFICITY: Expressed at high levels in kidney, adrenal gland, CC testis and brain. {ECO:0000269|PubMed:9473645}. CC -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase CC superfamily. Histone-lysine methyltransferase family. EZ subfamily. CC {ECO:0000255|PROSITE-ProRule:PRU00190}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH07135.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=AAL90764.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=AAL90765.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=BAA25018.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=BAE23827.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=BAE24446.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=BAE32680.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=BAE37674.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=EDL03899.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U60453; AAC53279.1; -; mRNA. DR EMBL; AB004817; BAA25018.1; ALT_INIT; mRNA. DR EMBL; AF104360; AAD54021.1; -; Genomic_DNA. DR EMBL; AF483490; AAL90764.1; ALT_INIT; mRNA. DR EMBL; AF483491; AAL90765.1; ALT_INIT; mRNA. DR EMBL; AK045374; BAC32334.1; -; mRNA. DR EMBL; AK138942; BAE23827.1; ALT_INIT; mRNA. DR EMBL; AK140694; BAE24446.1; ALT_INIT; mRNA. DR EMBL; AK154565; BAE32680.1; ALT_INIT; mRNA. DR EMBL; AK164192; BAE37674.1; ALT_INIT; mRNA. DR EMBL; AL590969; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH466677; EDL03899.1; ALT_INIT; Genomic_DNA. DR EMBL; BC007135; AAH07135.1; ALT_INIT; mRNA. DR RefSeq; NP_001390738.1; NM_001403809.1. [P70351-1] DR RefSeq; NP_001390744.1; NM_001403815.1. [P70351-2] DR RefSeq; NP_031996.1; NM_007970.4. DR AlphaFoldDB; P70351; -. DR SMR; P70351; -. DR BioGRID; 199563; 19. DR DIP; DIP-56992N; -. DR FunCoup; P70351; 3044. DR IntAct; P70351; 8. DR STRING; 10090.ENSMUSP00000102906; -. DR ChEMBL; CHEMBL6066858; -. DR GlyGen; P70351; 1 site, 1 N-linked glycan (1 site). DR iPTMnet; P70351; -. DR PhosphoSitePlus; P70351; -. DR jPOST; P70351; -. DR PaxDb; 10090-ENSMUSP00000102906; -. DR PeptideAtlas; P70351; -. DR ProteomicsDB; 275809; -. [P70351-1] DR ProteomicsDB; 275810; -. [P70351-2] DR Antibodypedia; 1432; 446 antibodies from 40 providers. DR DNASU; 14055; -. DR Ensembl; ENSMPUT00000010229; ENSMPUP00000010067; ENSMPUG00000010144. DR Ensembl; ENSMUST00000100417.3; ENSMUSP00000097984.3; ENSMUSG00000006920.15. [P70351-2] DR Ensembl; ENSMUST00000107284.8; ENSMUSP00000102905.2; ENSMUSG00000006920.15. [P70351-1] DR GeneID; 14055; -. DR KEGG; mmu:14055; -. DR UCSC; uc007lnw.3; mouse. [P70351-2] DR UCSC; uc011yfk.2; mouse. [P70351-1] DR AGR; MGI:1097695; -. DR CTD; 2145; -. DR MGI; MGI:1097695; Ezh1. DR VEuPathDB; HostDB:ENSMUSG00000006920; -. DR eggNOG; KOG1079; Eukaryota. DR GeneTree; ENSGT00940000156604; -. DR HOGENOM; CLU_011342_0_0_1; -. DR InParanoid; P70351; -. DR OrthoDB; 6141102at2759; -. DR PhylomeDB; P70351; -. DR Reactome; R-MMU-212300; PRC2 methylates histones and DNA. DR BioGRID-ORCS; 14055; 2 hits in 82 CRISPR screens. DR PRO; PR:P70351; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; P70351; protein. DR Bgee; ENSMUSG00000006920; Expressed in ciliary body and 253 other cell types or tissues. DR ExpressionAtlas; P70351; baseline and differential. DR GO; GO:0000781; C:chromosome, telomeric region; IGI:ARUK-UCL. DR GO; GO:0035098; C:ESC/E(Z) complex; IDA:UniProtKB. DR GO; GO:0000792; C:heterochromatin; IDA:ARUK-UCL. DR GO; GO:0005654; C:nucleoplasm; ISO:GO_Central. DR GO; GO:0005634; C:nucleus; IDA:MGI. DR GO; GO:0003682; F:chromatin binding; ISO:GO_Central. DR GO; GO:0046976; F:histone H3K27 methyltransferase activity; IDA:MGI. DR GO; GO:0140951; F:histone H3K27 trimethyltransferase activity; ISO:GO_Central. DR GO; GO:0140693; F:molecular condensate scaffold activity; ISO:GO_Central. DR GO; GO:0031491; F:nucleosome binding; ISO:GO_Central. DR GO; GO:0016279; F:protein-lysine N-methyltransferase activity; ISO:GO_Central. DR GO; GO:0003714; F:transcription corepressor activity; IDA:ARUK-UCL. DR GO; GO:0006338; P:chromatin remodeling; IDA:ARUK-UCL. DR GO; GO:0140718; P:facultative heterochromatin formation; IDA:GO_Central. DR GO; GO:0036333; P:hepatocyte homeostasis; IGI:MGI. DR GO; GO:0031507; P:heterochromatin formation; IDA:ARUK-UCL. DR GO; GO:0097421; P:liver regeneration; IGI:MGI. DR GO; GO:0045892; P:negative regulation of DNA-templated transcription; IBA:GO_Central. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:ARUK-UCL. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:GO_Central. DR GO; GO:1904772; P:response to tetrachloromethane; IGI:MGI. DR GO; GO:0031509; P:subtelomeric heterochromatin formation; IGI:ARUK-UCL. DR CDD; cd00167; SANT; 1. DR CDD; cd19217; SET_EZH1; 1. DR FunFam; 2.170.270.10:FF:000001; Putative histone-lysine N-methyltransferase EZH2; 1. DR Gene3D; 2.170.270.10; SET domain; 1. DR InterPro; IPR026489; CXC_dom. DR InterPro; IPR045318; EZH1/2-like. DR InterPro; IPR048358; EZH1/2_MCSS. DR InterPro; IPR021654; EZH1/EZH2_N. DR InterPro; IPR044438; EZH1_SET. DR InterPro; IPR041343; PRC2_HTH_1. DR InterPro; IPR041355; Pre-SET_CXC. DR InterPro; IPR001005; SANT/Myb. DR InterPro; IPR001214; SET_dom. DR InterPro; IPR046341; SET_dom_sf. DR InterPro; IPR033467; Tesmin/TSO1-like_CXC. DR PANTHER; PTHR45747; HISTONE-LYSINE N-METHYLTRANSFERASE E(Z); 1. DR PANTHER; PTHR45747:SF1; HISTONE-LYSINE N-METHYLTRANSFERASE EZH1; 1. DR Pfam; PF21358; Ezh2_MCSS; 1. DR Pfam; PF11616; EZH2_WD-Binding; 1. DR Pfam; PF18118; PRC2_HTH_1; 1. DR Pfam; PF18264; preSET_CXC; 1. DR Pfam; PF00856; SET; 1. DR SMART; SM01114; CXC; 1. DR SMART; SM00717; SANT; 2. DR SMART; SM00317; SET; 1. DR SUPFAM; SSF82199; SET domain; 1. DR PROSITE; PS51633; CXC; 1. DR PROSITE; PS50280; SET; 1. PE 1: Evidence at protein level; KW Alternative splicing; Chromatin regulator; Isopeptide bond; KW Methyltransferase; Nucleus; Reference proteome; Repressor; KW S-adenosyl-L-methionine; Transcription; Transcription regulation; KW Transferase; Ubl conjugation. FT CHAIN 1..747 FT /note="Histone-lysine N-methyltransferase EZH1" FT /id="PRO_0000213991" FT DOMAIN 504..606 FT /note="CXC" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00970" FT DOMAIN 613..728 FT /note="SET" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00190" FT REGION 188..231 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 368..414 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 491..496 FT /note="Nuclear localization signal" FT /evidence="ECO:0000255" FT COMPBIAS 194..211 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 369..381 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 382..393 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 395..414 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CROSSLNK 327 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q92800" FT VAR_SEQ 555..747 FT /note="QNRFPGCRCKTQCNTKQCPCYLAVRECDPDLCLTCGASEHWDCKVVSCKNCS FT IQRGLKKHLLLAPSDVAGWGTFIKESVQKNEFISEYCGELISQDEADRRGKVYDKYMSS FT FLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVVMVNGDHRIGIFAKRAIQAGEELF FT FDYRYSQADALKYVGIERETDVF -> KSTLLSPSSTQVVGLGVPRLFSPAP (in FT isoform 2)" FT /evidence="ECO:0000303|PubMed:16141072" FT /id="VSP_036388" FT CONFLICT 84 FT /note="T -> A (in Ref. 5; BAE32680)" FT /evidence="ECO:0000305" FT CONFLICT 446 FT /note="H -> Y (in Ref. 2; AAD54021)" FT /evidence="ECO:0000305" FT CONFLICT 452 FT /note="N -> Y (in Ref. 2; AAD54021)" FT /evidence="ECO:0000305" SQ SEQUENCE 747 AA; 85188 MW; 43CECFBDF3E49192 CRC64; MDIASPPTSK CITYWKRKVK SEYMRLRQLK RLQANMGAKA LYVANFAKVQ EKTQILNEEW KKLRVQPVQP MKPVSGHPFL KKCTIESIFP GFDSQDMLMR SLNTVALVPI MYSWSPLQQN FMVEDETVLC NIPYMGDEVK EEDETFIEEL INNYDGKVHG EEEMIPGSVL ISDAVFLELV DALNQYSDEE EDGHNDPSDG KQDDSKEDLP VTRKRKRHAI EGNKKSSKKQ FPNDMIFSAI ASMFPENGVP DDMKERYREL TEMSDPNALP PQCTPNIDGP NAKSVQREQS LHSFHTLFCR RCFKYDCFLH PFHATPNVYK RKNKEIKIEP EPCGTDCFLL LEGAKEYAML HNPRSKCSGR RRRRHPVVSA SCSNASASAM AETKEGDSDR DTGNDWASSS SEANSRCQTP TKQKASPAPA QLCVVEAPSE PVEWTGAEES LFRVFHGTYF NNFCSIARLL GTKTCKQVFQ FAVKESLILK LPTDELMNPA QKKKRKHRLW AAHCRKIQLK KDNNSTQVYN YQPCDHPDRP CDSTCPCIMT QNFCEKFCQC SPDCQNRFPG CRCKTQCNTK QCPCYLAVRE CDPDLCLTCG ASEHWDCKVV SCKNCSIQRG LKKHLLLAPS DVAGWGTFIK ESVQKNEFIS EYCGELISQD EADRRGKVYD KYMSSFLFNL NNDFVVDATR KGNKIRFANH SVNPNCYAKV VMVNGDHRIG IFAKRAIQAG EELFFDYRYS QADALKYVGI ERETDVF //